Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

14.500
-0.040-0.28%
Volume:18.86M
Turnover:272.87M
Market Cap:31.60B
PE:1.32
High:14.660
Open:14.560
Low:14.260
Close:14.540
Loading ...

US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies

Reuters
·
Yesterday

ProBio Opens Flagship US Facility for Cell and Gene Therapy in New Jersey

Reuters
·
27 Jun

Legend Biotech Corporation Concludes Annual General Meeting

Reuters
·
13 Jun

Genscript Biotech Grants Over 7.4 Million Restricted Shares Under Award Scheme

MT Newswires Live
·
12 Jun

GenScript Biotech Announces New Restricted Share Grant Plan for Employees and Consultants

Reuters
·
11 Jun

Legend Biotech Corporation Names Peter Salovey as Lead Independent Director

Reuters
·
05 Jun

Genscript Biotech's Myeloma Drug Shows Progression-Free Survival in One-Third of Patients During Study

MT Newswires Live
·
04 Jun

Legend Biotech Announces Promising Phase 1 Results for LB2102 CAR-T Therapy in Lung Cancer Patients

Reuters
·
03 Jun

Legend Biotech to Reveal New CARVYKTI Data for Multiple Myeloma at 2025 ASCO and EHA Meetings

Reuters
·
23 May

Legend Biotech Corporation to Host Investor Event During American Society of Clinical Oncology Annual Meeting

Reuters
·
19 May

BUZZ-Legend Biotech slips after brokerages cut PT

Reuters
·
14 May

Legend Biotech USA Inc. Signs Lease for New Global Headquarters in Bridgewater, New Jersey

Reuters
·
14 May

Legend Biotech Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Legend Biotech Reports Q1 2025: Net Loss Widens to $100.9M, License Revenue Falls by $2.9M, CARVYKTI® Sales Reach $369M

Reuters
·
13 May

Legend Biotech Corp expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
10 May

Genscript Biotech - Unit to Buy 300.0 Mln Series a Preferred Shares of Probio Cayman in Aggregate for US$225.1 Mln

THOMSON REUTERS
·
28 Apr

Bestzyme's Mellia™ Brazzein Receives FDA "No Questions" Letter, Bringing Creative Sugar Reduction Solution to Global Market

THOMSON REUTERS
·
27 Apr

Genscript Biotech Associate Logs $369 Million in Q1 Sales of CARVYKTI

MT Newswires Live
·
16 Apr

Genscript Biotech Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
10 Apr

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
09 Apr